Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Biosecure Act gains key backer in biotech champion Rep. Eshoo

Bay Area lawmaker’s co-sponsorship comes ahead of hearing that will provide early indication of possible changes to the bill

May 4, 2024 12:05 AM UTC

One of the biotech industry’s strongest allies in Congress, Rep. Anna Eshoo (D-Calif.), has signed on as a co-sponsor of the Biosecure Act, underscoring bipartisan support for the bill. Eshoo’s decision to endorse the bill comes as the House Oversight and Accountability Committee is preparing a markup hearing on the legislation.

The potential for the Biosecure Act (H.R. 7085) to restrict access to Chinese contract development and manufacturing organizations (CDMOs) has been a major concern for U.S. and multinational biopharmaceutical companies. Eshoo, however, has focused on the bill’s attempt to prevent Chinese companies from gaining access to U.S. genomic data. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article